Company intelligence / Profile preview

Neuro-Eye Diagnostic Systems

Ownership: Private
Development stage: Commercial

Overview

Neuro-Eye Diagnostic Systems developed the EyeCTester, an FDA-cleared mobile application that enables at-home or clinical Amsler Grid testing to monitor central/paracentral visual distortions. Clinical studies demonstrated equivalence to traditional paper-based Amsler grid tests with no increase in false positives. The system allows eyecare providers to remotely monitor patients’ vision changes and receive alerts when significant changes are detected.

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceSoftware as a Medical Device
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

EYE-SYNC

Commercial

Indications: Neurological disorders, Concussion, Brain health assessment

Partnerships

Not publicly disclosed.

Beyond the preview

Go deeper on Neuro-Eye Diagnostic Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro-Eye Diagnostic Systems.

Explore the full profile